% | $
Quotes you view appear here for quick access.

Endocyte, Inc. Message Board

  • lookahead22 lookahead22 Jul 18, 2014 11:27 AM Flag

    News Anytine for this Phase-1 study

    A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)
    This study is ongoing, but not recruiting participants.
    Merck Sharp & Dohme Corp.
    Information provided by (Responsible Party):
    Merck Sharp & Dohme Corp. Identifier:
    First received: September 17, 2012
    Last updated: July 17, 2014
    Last verified: July 2014

    Drug: Vintafolide
    Drug: Carboplatin
    Drug: Paclitaxel

    Estimated Enrollment: 94
    Study Start Date: December 2012
    Estimated Study Completion Date: September 2014
    Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)

3.20+0.05(+1.59%)Jul 27 4:00 PMEDT